Abstract
Postpartum depression (PPD) or, simply, postpartum are the most commonly used lay terms for describing major depressive disorder occurring in the postnatal period. Whether the disorder occurs de novo, is a relapse of a previous depressive episode, or has its origin in the antepartum period, depression after childbirth is associated with significant maternal and infant morbidity and, in worst cases, mortality. With most epidemiological studies demonstrating a prevalence of 10–13%, PPD is one of the most common complications of childbirth (1,2). Yet, the pathogenesis, natural history, and treatment of the disorder have been shrouded in mystery and myth as society and science has imbued motherhood with a cloak of sanctity that cuts both ways. Attempts to protect mothers and their offspring from unnecessary intrusions or potential harm have unwittingly limited detection of PPD in the clinical setting and the investigation of its pathogenesis and treatment in the scientific arena. p] Thus, PPD continues to be a major public health problem, with more than 400,000 women in the United States alone suffering each year from this potentially devastating disease. The overarching purpose of this chapter is to review the studies that provide the most rigorous and up-to-date findings regarding the detection, pathogenesis, and treatment of depression occurring in the postnatal period. In doing so, this chapter will enable the primary care provider to become more comfortable in assessing postpartum women and treating those who, in many cases, would otherwise go without care.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Epperson, C. N. (1999) Postpartum major depression: detection and treatment. Am. Fam. Physician 59, 2247–2254, 2259-2260.
O’Hara, M. W., Neunaber, D. J., and Zekoski, E. M. (1984) Prospective study of postpartum depression: prevalence, course, and predictive factors. J. Abnorm. Psychol. 93, 158–171.
Cox, J. L., Holden, J. M., and Sagovsky, R. (1987) Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br. J. Psychiatry 150, 782–786.
Peindl, K. S., Wisner, K. L., and Hanusa, B. H. (2004) Identifying depression in the first postpartum year: guidelines for office-based screening and referral. J. Affect. Disord. 80, 37–44.
Glasser, S., Barell, V., Boyko, V., et al. (2000) Postpartum depression in an Israeli cohort: demographic, psychosocial and medical risk factors. J. Psychosom. Obstet. Gynecol. 21, 99–108.
Wickberg, B. and Hwang, C. P. (1996) The Edinburgh Postnatal Depression Scale: validation on a Swedish community sample. Acta Psychiatr. Scand. 94, 181–184.
Beck, C. T. and Gable, R. K. (2000) Postpartum depression screening scale: development and psychometric testing. Nurs. Res. 49, 272–282.
Beck, C. T. and Gable, R. K. (2001) Comparative analysis of the performance of the Postpartum Depression Screening Scale with two other depression instruments. Nurs. Res. 50, 242–250.
Spitzer, R. L., Williams, J. B., Kroenke, K., et al. (1994) Utility of a new procedure for diagnosing mental disorders in primary care. The PRIME-MD 1000 study. JAMA 272, 1749–1756.
Spitzer, R. L., Williams, J. B., Kroenke, K., et al. (2000) Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetrics-Gynecology Study. Am. J. Obstet. Gynecol. 183, 759–769.
Gerstein, H. C. (1990) How common is postpartum thyroiditis? A methodologic overview of the literature. Arch. Intern. Med. 150, 1397–400.
Kokandi, A. A., Parkes, A. B., Premawardhana, L. D., et al. (2003) Association of postpartum thyroid dysfunction with antepartum hormonal and immunological changes. J. Clin. Endocrinol. Metab. 88, 1126–1132.
Lazarus, J. H. Thyroid dysfunction: reproduction and postpartum thyroiditis. (2002) Semin. Reprod. Med. 20, 381–388.
Muller, A. F., Drexhage, H. A., and Berghout, A. (2001) Postpartum thyroiditis and autoimmune thyroiditis in women of childbearing age: recent insights and consequences for antenatal and postnatal care. Endocr. Rev. 22, 605–630.
Oretti, R.G., Harris, B., Lazarus, J. H., et al. (2003) Is there an association between life events, postnatal depression and thyroid dysfunction in thyroid antibody positive women? Int. J. Soc. Psychiatry 49, 70–76.
Harris, B., Oretti, R., Lazarus, J., et al. (2002) Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br. J. Psychiatry 180, 327–330.
Kuijpens, J. L., Vader, H. L., Drexhage, H. A., et al. (2001) Thyroid peroxidase antibodies during gestation are a marker for subsequent depression postpartum. Eur. J. Endocrinol. 145, 579–584.
Hendrick, V., Altshuler, L., and Whybrow, P. (1998) Psychoneuroendocrinology of mood disorders. The hypothalamic-pituitary-thyroid axis. Psychiatr. Clin. North Am. 21, 277–292.
O’Hara, M..W., Zekoski, E.M., Philipps, L. H., and Wright, E. J. (1990) Controlled prospective study of postpartum mood disorders: comparison of childbearing and nonchildbearing women. J. Abnorm. Psychol. 99, 3–15.
Stein, G. (1982) The maternity blues. In: Brockington, I. F. and Kumar, R.,eds. Motherhood and Mental Illness. New York: Grune and Stratton, pp. 119–154.
Handley, S. L., Dunn, T. L., Waldron, G., et al. (1980) Tryptophan, cortisol and puerperal mood. Br. J. Psychiatry 136, 498–508.
Hannah, P., Adams, D., Lee, A., et al. (1992) Links between early post-partum mood and post-natal depression. Br. J. Psychiatry 160, 777–780.
Cox, J. L., Connor, Y. M., Henderson, I., et al. (1983) Prospective study of the psychiatric disorders of childbirth by self report questionnaire. J. Affect. Disord. 5, 1–7.
Diagnostic and Statistical Manual of Mental Disorders, 4th ed. (DSM-IV). (1994) Washington, DC: American Psychiatric Association.
Wisner, K. L., Peindl, K., and Hanusa, B. H. (1994) Symptomatology of affective and psychotic illnesses related to childbearing. J. Affect. Disord. 30, 77–87.
Brockington, I. F., Cernik, K. F., Schofield, E. M., et al. (1981) Puerperal psychosis. Phenomena and diagnosis. Arch. Gen. Psychiatry 38, 829–833.
Wisner, K L., Peindl, K. S., Gigliotti, T., et al. (1999) Obsessions and compulsions in women with postpartum depression. J. Clin. Psychiatry 60, 176–180.
Stanton, J., Simpson, A., and Wouldes, T. (2000) A qualitative study of filicide by mentally ill mothers. Child Abuse Neglect 24, 1451–1460.
Chandra, P. S., Venkatasubramanian, G., and Thomas, T. (2002) Infanticidal ideas and infanticidal behavior in Indian women with severe postpartum psychiatric disorders. J. Nerv. Ment. Dis. 190, 457–461.
Jennings, K. D., Ross, S., Popper, S., et al. (1999) Thoughts of harming infants in depressed and nondepressed mothers. J. Affect. Disord. 54(1-2), 21–28.
O’Hara, M. W., Schlechte, J. A., Lewis, D. A., et al. (1991) Prospective study of postpartum blues. Biologic and psychosocial factors. Arch. Gen. Psychiatry 48, 801–806.
Sugawara, M., Toda, M. A., Shima, S., et al. (1997) Premenstrual mood changes and maternal mental health in pregnancy and the postpartum period. J. Clin. Psychol. 53, 225–232.
Campbell, J. C., Poland, M. L., Waller, J. B., et al. (1992) Correlates of battering during pregnancy. Res. Nurs. Health 15, 219–226.
Cox, J. L. (1982) Medical management, culture, and mental illness. Br. J. Hosp. Med. 27, 533–537.
O’Hara, M. W. (1986) Social support, life events, and depression during pregnancy and the puerperium. Arch. Gen. Psychiatry 43, 569–573.
O’Hara, M. W., Rehm, L. P., and Campbell S. B. (1983) Postpartum depression. A role for social network and life stress variables. J. Nerv. Ment. Dis. 171, 336–341.
Paykel, E. S., Emms, E. M., Fletcher, J., et al. (1980) Life events and social support in puerperal depression. Br. J. Psychiatry 136, 339–346.
Kendell, R.E. (1985) Emotional and physical factors in the genesis of puerperal mental disorders. J. Psychosom. Res. 29, 3–11.
Turton, P., Hughes, P., Evans, C. D. H., et al. (2001). Incidence, correlates and predictors of post-traumatic stress disorder in the pregnancy after stillbirth. Br. J. Psychiatry 178, 556–560.
O’Hara, M. W., Rehm, L. P., and Campbell, S. B. (1982) Predicting depressive symptomatology: cognitive-behavioral models and postpartum depression. J. Abnorm. Psychol. 91, 457–461.
Playfair, H. R. and Gowers, J. I. (1981) Depression following childbirth-a search for predictive signs. J. Roy. Coll. Gen. Pract. 31, 201–208.
Alder, E. M. and Cox, J. L. (1983) Breast feeding and post-natal depression. J. Psychosom. Res. 27, 139–144.
Parry, B. L., Sorenson, D. L., Meliska, C. J., et al. (2003) Hormonal basis of mood and postpartum disorders. Curr. Women’s Health Rep. 3, 230–235.
Bloch, M., Schmidt, P. J., Danaceau, M., et al. (2000) Effects of gonadal steroids in women with a history of postpartum depression. Am. J. Psychiatry 157, 924–930.
Wieck, A., Kumar, R., Hirst, A. D., et al. (1991) Increased sensitivity of dopamine receptors and recurrence of affective psychosis after childbirth. Br. Med. J. 303(6803), 613–616.
Ahokas, A. and Aito, M. (1990) Role of estradiolin puerperal psychosis.Psychopharmacology 147, 108–110.
Ahokas, A., Aito, M., and Rimon, R. (2000) Positive treatment effect of estradiol in postpartum psychosis: a pilot study. J. Clin. Psychiatry 61, 166–169.
Ahokas, A., Kaukoranta, J., Wahlbeck, K., et al. (2001) Estrogen deficiency in severe postpartum depression: successful treatment with sublingual physiologic 17beta-estradiol: a preliminary study. J. Clin. Psychiatry 62, 332–336.
Ross L. E., Sellers E. M., Gilber Evans, S. E., et al. (2004) Mood changes during pregnancy and the postpartum period: development of a biopsychosocial model. Acta Psychiatr. Scand. 109, 457–466.
Lawrie T. A., Hofmeyr G. J., De Jager, M., et al. (1998) A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones. Br. J. Obstet. Gynaecol. 105, 1082–1090.
Butler, J. and Leonard, B. E. (1986) Post-partum depression and the effect of nomifensine treatment. Int. Clin. Psychopharmacol. 1, 244–252.
Ballinger, C. B., Kay, D. S., Naylor, G. J., et al. (1982) Some biochemical findings during pregnancy and after delivery in relation to mood change. Psychol. Med. 12, 549–556.
Heidrich, A., Schleyer, M., Spingler, H., et al. (1994) Postpartum blues: relationship between not-protein bound steroid hormones in plasma and postpartum mood changes. J. Affect. Disord. 30, 93–98.
Harris, B., Johns, S., Fung, H., et al. (1989) The hormonal environment of postnatal depression. Br. J. Psychiatry 154, 660–667.
Harris, B., Lovett, L., Newcombe, R. G., et al. (1994) Maternity blues and major endocrine changes: Cardiff puerperal mood and hormone study II. Br. Med. J. 308, 949–953.
Nott, P.N., Franklin, M., Armitage, C, et al. (1976) Hormonal changes and mood in the puerperium. Br. J. Psychiatry 128, 379–383.
Singh, B., Gilhotra, M., Smith, R, et al. (1986) Post-partum psychoses and the dexamethasone suppression test. J. Affect. Disord. 11, 173–177.
Harris, B., Lovett, L., Smith, J., et al. (1996) Cardiff puerperal mood and hormone study. III. Postnatal depression at 5 to 6 weeks postpartum, and its hormonal correlates across the peripartum period. Br. J. Psychiatry 168, 739–744.
Magiakou, M. A., Mastorakos, G., Rabin, D., et al. (1996) Hypothalamic corticotropin-releasing hormone suppression during the postpartum period: implications for the increase in psychiatric manifestations at this time. J. Clin. Endocrinol. Metab. 81, 1912–1917.
Stewart, D. E., Addison, A. M., Robinson, G. E., et al. (1988) Thyroid function in psychosis following childbirth. Am. J. Psychiatry 145, 1579–1581.
Bokhari, R., Bhatara, V. S., Bandettini, F., et al. (1998) Postpartum psychosis and postpartum thyroiditis. Psychoneuroendocrinology 23, 643–650.
Smith, J. E. (1990) Pregnancy complicated by thyroid disease. J. Nurse-Midwifery 35, 143–149.
Glover, V., Liddle, P., Taylor, A., et al. (1994) Mild hypomania (the highs) can be a feature of the first postpartum week. Association with later depression. Br. J. Psychiatry 164, 517–521.
Harris, B. Oretti, R., Lazarus, J., et al. (2002) Randomised trial of thyroxine to prevent postnatal depression in thyroid-antibody-positive women. Br. J. Psychiatry 180, 327–330.
Epperson, C. N., Haga, K., Mason, G. F., et al. (2002) Cortical gammaaminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: a proton magnetic resonance spectroscopy study. Arch. Gen. Psychiatry 59, 851–858.
Epperson, C. N., Jatlow, P. I., Czarkowski, K., et al. (2003) Maternal fluoxetine treatment in the postpartum period: effects on platelet serotonin and plasma drug levels in breast-feeding mother-infant pairs. Pediatrics 112, e425.
Demarest, K. T., Riegle, G. D., and Moore, K. E. (1984) Adenohypophysialdopamine content during physiological changes in prolactin secretion. Endocrinology 115, 2091–2097.
Van Hartesveldt, C. and Joyce, J. N. (1986) Effects of estrogen on the basal ganglia. Neurosci. Biobehav. Rev. 10, 1–14.
Wieck, A. (1989) Endocrine aspects of postnatal mental disorders. Baillieres Clin. Obstet. Gynaecol. 3, 857–877.
Ettigi, P., Lal, S., Martin, J. B, et al. (1975) Effect of sex, oral contraceptives, and glucose loading on apomorphine-induced growth hormone secretion. J. Clin. Endocrinol. Metab. 40, 1094–1098.
Cookson, J. C. (1985) The neuroendocrinology of mania. J. Affect. Disord. 233–241.
O’Hara, M. W., Schlechte, J. A., Lewis D. A., et al. (1991) Controlled prospective study of postpartum mood disorders: psychological, environmental, and hormonal variables. J. Abnorm. Psychol. 100, 63–73.
Pedersen, C. A., Stern, R. A., Pate, J., et al. (1993) Thyroid and adrenal measures during late pregnancy and the puerperium in women who have been major depressed or who become dysphoric postpartum. J. Affect. Disord. 29(2-3), 201–211.
Ryan, A. S., Pratt, W. F., Wysong, J. L., et al. (1991) A comparison of breastfeeding data from the National Surveys of Family Growth and the Ross Laboratories Mothers Surveys. Am. J. Public Health 81, 1049–1052.
Anonymous. (1997) Breast-feeding and the use of human milk. American Academy of Pediatrics work group on breast-feeding. Pediatrics 100, 1035–1039.
Wright, A. L., Holberg, C. J., Martinez, F. D., et al. (1989) Breast feeding and lower respiratory tract illness in the first year of life. Group Health Medical Associates. Br. Med. J. 299, 946–949.
Pisacane, A., Graziano, L., Mazzarella, G., et al. (1992) Breast-feeding and urinary tract infection. J. Pediatr. 120, 87–89.
Aniansson, G., Alm, B., Andersson, B., et al. (1994) A prospective cohort study on breast-feeding and otitis media in Swedish infants. Pediatr. Infect. Dis. J. 13, 183–188.
Takala, A. K. (1989) Epidemiologic characteristics and risk factors for invasive Haemophilus influenzae type b disease in a population with high vaccine efficacy. Pediatr. Infect. Dis. J. 8, 343–346.
Halken, S., Host, A., Hansen, L. G., et al. (1992) Effect of an allergy prevention programme on incidence of atopic symptoms in infancy. A prospective study of 159 "e;high-risk"e; infants. Allergy 47, 545–553.
Ford, R. P., Taylor, B. J., Mitchell, E. A., et al. (1993) Breast-feeding and the risk of sudden infant death syndrome. Int. J. Epidemiol. 22, 885–890.
Mayer, E., Hamman, R., Gay, E., et al. (1988) Reduced risk of IDDM among breastfed children. Diabetes 37, 1625–1632.
Fergusson, D. M., Beautrais, A. L., and Silva, P. A. (1982) Breast-feeding and cognitive development in the first seven years of life. Soc. Sci. Med. 16, 1705–1708.
Lucas, A., Morley, R., Cole, T., et al. (1992) Breast milk and subsequent intelligence quotient in children born preterm. Lancet 339, 261–264.
Vestergaard, M., Obel, C., Henriksen, T., et al. (1999) Duration of breast-feeding and developmental milestones during the latter half of infancy. ActaPaediatr. 88, 1327–1332.
Winans, E. A. (2001) Antipsychotics and breast-feeding. J. Hum. Lactation 17, 344–347.
Craig, M. and Abel, K. (2001) Drugs in pregnancy. Prescribing for psychiatric disorders in pregnancy and lactation. Best Pract. Res. Clin. Obstet. Gynaecol. 15, 1013–1030.
Buist, A. (2001) Treating mental illness in lactating women. Medscape Womens Health 6, 3.
Spencer, J. P., Gonzalez, L. S., 3rd., and Barnhart, D. J. (2001) Medications in the breast-feeding mother. Am. Fam. Physician 64, 119–126.
Burt, V. K., Suri, R., Altshuler, L. L., et al. (2001) The use of psychotropic medications during breast-feeding. Am. J. Psychiatry 158, 1001–1009.
Dodd, S., Maguire, K. P., Burrows, G. D., et al. (2000) Nefazodone in the breast milk of nursing mothers: a report of two patients. J. Clin. Psychopharmacol. 20, 717–718.
Tenyi, T., Csabi, G., and Trixler, M. (2000) Antipsychotics and breast-feeding: a review of the literature. Paediatr. Drugs 2, 23–28.
Ito, S. (2000) Drug therapy for breast-feeding women. N. Engl. J. Med. 343, 118–126.
Briggs, G., Freeman, R. K., and Yaffe, S. J., eds. (2002) Drugs in Pregnancy and Lactation: A Reference Guide to Fetal and Neonatal Risk, 6th ed. Baltimore: Williams and Wilkins.
Stowe, Z. N., Owens, M. J., Landry, J. C, et al. (1997) Sertraline and desmethylsertraline in human breast milk and nursing infants [see comment]. Am. J. Psychiatry 154, 1255–1260.
Stowe, Z. N., Cohen, L. S., Hostetter, A., et al. (2000) Paroxetine in human breast milk and nursing infants. Am. J. Psychiatry 157, 185–189.
Hendrick, V., Stowe, Z. N., Altshuler, L. L., et al. (2001) Fluoxetine and norfluoxetine concentrations in nursing infants and breast milk. Biol. Psychiatry 50, 775–782.
Dodd, S., Stocky, A., Buist, A., Burrows, G.D.,and Norman, T.R. (2001) Sertraline analysis in the plasma of breast-fed infants. Australian & New Zealand J. Psych. 35(4), 545–546.
Weissman, A. M., Barcey, T. L., Hartz, A. J., et al. (2004) Pooled analysis of antidepressant levels in lactating mothers, breast milk and nursing infants. Am. J. Psychiatry 161, 1066–1078.
Hendrick, V., Fukuchi, A., Altshuler, L., et al. (2001) Use of sertraline, paroxetine and fluvoxamine by nursing women. Br. J. Psychiatry 179, 163–166.
Dodd, S., Buist, A., and Norman, T. R. (2000) Antidepressants and breast-feeding: a review of the literature. Paediatr. Drugs 2, 183–192.
Frey, O. R., Scheidt, P., and von Brenndorff, A. I. (1999) Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann. Pharmacother. 33, 690–693.
Ilett, K. F., Hackett, L. P., Dusci, L. J., et al. (1998) Distribution and excretion of venlafaxine and O-desmethylvenlafaxine in human milk. Br. J. Clin. Pharmacol. 45, 459–462.
Yoshida, K., Smith, B., and Kumar, R. C. (1997) Fluvoxamine in breast-milk and infant development. Br. J. Clin. Pharmacol. 44, 210–211.
Epperson, C. N., Anderson, G. M., and McDougle, C. J. (1997) Sertraline and breast-feeding. N. Engl. J. Med. 336, 1189–1190.
Wisner, K. L. and Perel, J. M. (1996) Nortriptyline treatment of breast-feeding women. Am. J. Psychiatry 153, 295.
Breyer-Pfaff, U., Nill, K., Entenmann K. N., et al. (1995) Secretion of amitriptyline and metabolites into breast milk. Am. J. Psychiatry 152, 812–813.
Wisner, K. L., Perel, J. M., and Foglia, J. P. (1995) Serum clomipramine and metabolite levels in four nursing mother-infant pairs. J. Clin. Psychiatry 56, 17–20.
Buist, A., Norman, T. R., and Dennerstein, L. (1993) Mianserin in breast milk. Br. J. Clin. Pharmacol. 36, 133–134.
Wisner, K. L. and Perel J. M. (1991) Serum nortriptyline levels in nursing mothers and their infants. Am. J. Psychiatry 148, 1234–1236.
Isenberg, K. E. (1990) Excretion of fluoxetine in human breast milk. J. Clin. Psychiatry 51, 169.
Stancer, H. C. and Reed, K. L. (1986) Desipramine and 2-hydroxydesipramine in human breast milk and the nursing infant’s serum. Am. J. Psychiatry 143, 1597–600.
Kemp, J., Ilett, K. F., Booth J., et al. (1985) Excretion of doxepin and N-desmethyldoxepin in human milk. Br. J. Clin. Pharmacol. 20, 497–499.
Brixen-Rasmussen, L., Halgrener, J., and Jorgensen, A. (1982) Amitriptyline and nortriptyline excretion in human breast milk. Psychopharmacology 76, 94–95.
Bader, T. F. and Newman, K. (1980) Amitriptyline in human breast milk and the nursing infant’s serum. Am. J. Psychiatry 137, 855–856.
Erickson, S. H., Smith, G. H., and Heidrich, F. (1979) Tricyclics and breast feeding. Am. J. Psychiatry 136, 1483–1484.
Chambers, C. D., Anderson, P. O., Thomas, R. G., et al. (1999) Weight gain in infants breastfed by mothers who take fluoxetine. Pediatrics 104(5), e61.
Brent, N. B. and Wisner K. L. (1998) Fluoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin. Pediatr. 37, 41–44.
Oo, C. Y., Kuhn, R. J., Desai, N., Wright, C. E, et al. (1995) Pharmacokinetics in lactating women: prediction of alprazolam transfer into milk. Br. J. Clin. Pharmacol. 40, 231–236.
Lebedevs, T. H., Wojnar-Horton R. E., Yapp, P., et al. (1992) Excretion of temazepam in breast milk. Br. J. Clin. Pharmacol. 33, 204–206.
Soderman, P. and Matheson, I. (1988) Clonazepam in breast milk. Eur. J. Pediatr. 147, 212–213.
Wretlind, M. (1987) Excretion of oxazepam in breast milk. Eur. J. Clin. Pharmacol. 33, 209–210.
Summerfield, R. J. and Nielsen, M. S. (1985) Excretion of lorazepam into breast milk. Br. J. Anaesth. 57, 1042–1043.
Wesson, D. R., Camber, S., Harkey, M., et al. (1985) Diazepam and desmethyldiazepam in breast milk. J. Psychoactive Drugs 17, 55–56.
Fisher, J. B., Edgren, B. E., Mammel, M. C., et al. (1985) Neonatal apnea associated with maternal clonazepam therapy: a case report. Obstet. Gynecol. 66(3 Suppl.), 34S–35S.
Humpel, M., Stoppelli, I., Milia, S., et al. (1982) Pharmacokinetics and biotransformation of the new benzodiazepine, lormetazepam, in man. III. Repeated administration and transfer to neonates via breast milk. Eur. J. Clin. Pharmacol. 21, 421–425.
Kok, T. H., Taitz, L. S., Bennett, M. J., et al. (1982) Drowsiness due to clemastine transmitted in breast milk. Lancet 1, 914–915.
Brandt, R. (1976) Passage of diazepam and desmethyldiazepam into breast milk. Arzneimittel-Forschung 26, 454–457.
Erkkola, R. and Kanto, J. (1972) Diazepam and breast-feeding. Lancet 1(7762), 1235–1236.
Liporace, J., Kao, A., and D’Abreu, A. (2004) Concerns regarding lamotrigine and breast-feeding. Epilepsy Behav. 5, 102–105.
Frey, B., Braegger, C. P., and Ghelfi, D. (2002) Neonatal cholestatic hepatitis from carbamazepine exposure during pregnancy and breast feeding. Ann. Pharmacother. 36, 644–647.
Ohman, I., Vitols, S., and Tomson, T. (2000) Lamotrigine in pregnancy: pharmacokinetics during delivery, in the neonate, and during lactation. Epilepsia 41, 709–713.
Piontek, C. M., Baab, S., Peindl, K. S., et al. (2000) Serum valproate levels in 6 breast-feeding mother-infant pairs. J. Clin. Psychiatry 61, 170–172.
Wisner, K. L. and Perel, J. M. (1998) Serum levels of valproate and carbamazepine in breast-feeding mother-infant pairs. J. Clin. Psychopharmacol. 18, 167–169.
Rambeck, B., Kurlemann, G., Stodieck, S. R., et al. (1997) Concentrations of lamotrigine in a mother on lamotrigine treatment and her newborn child. Eur. J. Clin. Pharmacol. 51, 481–484.
Tomson, T., Ohman, I., and Vitols, S. (1997) Lamotrigine in pregnancy and lactation: a case report. Epilepsia 38, 1039–1041.
Stahl, M. M., Neiderud, J., and Vinge, E. (1997) Thrombocytopenic purpura and anemia in a breast-fed infant whose mother was treated with valproic acid. J. Pediatr. 130, 1001–1003.
Frey, B., Schubiger, G., and Musy, J. P. (1990) Transient cholestatic hepatitis in a neonate associated with carbamazepine exposure during pregnancy and breastfeeding. Eur. J. Pediatr. 150, 136–138.
Schou, M. (1990) Lithium treatment during pregnancy, delivery, and lactation: an update. J. Clin. Psychiatry 51, 410–413.
Tsuru, N., Maeda, T., and Tsuruoka, M. (1988) Three cases of delivery under sodium valproate-placental transfer, milk transfer and probable teratogenicity of sodium valproate. Jpn. J. Psychiatry Neurol. 42, 89–96.
Bardy, A. H., Hiilesmaa, V. K., and Teramo, K. A. (1987) Serumphenytoin during pregnancy, labor and puerperium. Acta Neurol. Scand. 75, 374–375.
Pittard, W. B., 3rd. and O’Neal, W., Jr. (1986) Amitriptyline excretion in human milk. J. Clin. Psychopharmacol. 6, 383–384.
von Unruh, G. E., Froescher, W., Hoffmann, F., et al. (1984) Valproic acid in breast milk: how much is really there? Ther. Drug Monit. 6, 272–276.
Froescher, W., Eichelbaum, M., Niesen, M., et al. (1984) Carbamazepine levels in breast milk. Ther. Drug Monit. 6, 266–271.
Kuhnz, W., Jager-Roman, E., Rating, D., et al. (1983) Carbamazepine and carbamazepine-10, 11-epoxide during pregnancy and postnatal period in epileptic mother and their nursed infants: pharmacokinetics and clinical effects. Pediatr. Pharmacol. 3(3-4), 199–208.
Philbert, A. and Dam, M. (1982) The epileptic mother and her child. Epilepsia 23, 85–99.
Nau, H,. Rating, D., Koch, S., et al. (1981) Valproic acid and its metabolites: placental transfer, neonatal pharmacokinetics, transfer via mother’s milk and clinical status in neonates of epileptic mothers. J. Pharmacol. Exp. Ther. 219, 768–777.
Niebyl, J. R., Blake, D. A., Freeman, J. M., et al. (1979) Carbamazepine levels in pregnancy and lactation. Obstet. Gynecol. 53, 139–140.
Sovner, R. and Orsulak, P. J. (1979) Excretion of imipramine and desipramine in human breast milk. Am. J. Psychiatry 136(4A), 451–452.
Alexander, F. W. (1979) Sodium valproate and pregnancy. Arch. Dis. Child. 54, 240.
Dickinson, R. G., Harland, R. C., Lynn, R. K., et al. (1979) Transmission of valproic acid (Depakene) across the placenta: half-life of the drug in mother and baby. J. Pediatr. 94, 832–835.
Pynnonen, S., Kanto, J., Sillanpaa, M., et al. (1977) Carbamazepine: placental transport, tissue concentrations in foetus and newborn, and level in milk. Acta Pharmacol. Toxicol. 41, 244–253.
Skausig, O. B. and Schou, M. (1977) [Breast feeding during lithium therapy. [Danish] Ugeskr. Laeg. 139, 400–401.
Sykes, P. A., Quarrie, J., and Alexander, F. W. (1976) Lithium carbonate and breast-feeding. Br. Med. J. 2, 1299.
Pynnonen, S. and Sillanpaa, M. (1975) Letter: carbamazepine and mother’s milk. Lancet 2(7934), 563.
Schou, M. and Amdisen, A. (1973) Lithium and pregnancy. 3. Lithium ingestion by children breast-fed by women on lithium treatment. Br. Med. J. 2, 138.
Tunnessen, W. W., Jr. and Hertz, C. G. (1972) Toxic effects of lithium in newborn infants: a commentary. J. Pediatr. 81, 804–807.
Fries, H. (1970) Lithium in pregnancy. Lancet 1, 1233.
Weinstein, M. R. and Goldfield, M. (1969) Lithium carbonate treatment during pregnancy; report of a case. Dis. Nerv. Syst. 30, 828–832.
Ilett, K. F., Hackett, L. P., Kristensen, J. H., et al. (2004) Transfer of risperidone and 9-hydroxyrisperidone into human milk. Ann. Pharmacother. 38, 273–276.
Ambresin, G., Berney, P., Schulz, P., et al. (2004) Olanzapine excretion into breast milk: a case report. J. Clin. Psychopharmacol. 24, 93–95.
Gardiner, S. J., Kristensen, J. H., Begg, E. J., et al. (2003) Transfer of olanzapine into breast milk, calculation of infant drug dose, and effect on breast-fed infants. Am. J. Psychiatry 160(8), 1428–1431.
Tenyi, T., Csabi, G., and Trixler, M. (2000) Antipsychotics and breast-feeding: a review of the literature. Paediatr. Drugs 2, 23–28.
Hill, R. C., McIvor, R. J., Wojnar-Horton, R. E., et al. (2000) Risperidone distribution and excretion into human milk: case report and estimated infant exposure during breast-feeding. J. Clin. Psychopharmacol. 20, 285–286.
Barnas, C., Bergant, A., Hummer, M., et al. (1994) Clozapine concentrations in maternal and fetal plasma, amniotic fluid, and breast milk. Am. J. Psychiatry 151, 945.
Olesen, O. V., Bartels, U., and Poulsen, J. H. (1990) Perphenazine in breast milk and serum. Am. J. Psychiatry 147, 1378–1379.
Whalley, L. J., Blain, P. G., and Prime, J. K. (1981) Haloperidol secreted in breast milk. Br. Med. J. Clin. Res. Ed. 282, 1746–1747.
Stewart, R. B., Karas, B., and Springer, P. K. (1980) Haloperidol excretion in human milk. Am. J. Psychiatry 137, 849–850.
Wiles, D. H., Orr, M. W., and Kolakowska, T. (1978) Chlorpromazine levels in plasma and milk of nursing mothers. Br. J. Clin. Pharmacol. 5, 272–273.
Birnbaum, C. S., Cohen, L. S., Bailey, J. W., et al. (1999) Serum concentrations of antidepressants andbenzodiazepines in nursing infants: a case series. Pediatrics 104(1), e11.
Dusci, L. J., Good, S. M., Hall, R. W., et al. (1990) Excretion of diazepam and its metabolites in human milk during withdrawal from combination high dose diazepam and oxazepam. Br. J. Clin. Pharmacol. 29, 123–126.
Patrick, M. J., Tilstone, W. J., and Reavey, P. (1972) Diazepam and breast-feeding. Lancet 1, 542–544.
Pons, G., Francoual, C., Guillet P., et al. (1989) Zolpidem excretion in breast milk. Eur. J. Clin. Pharmacol. 37, 245–248.
Darwish, M., Martin, P. T., Cevallos, W. H., et al. (1999) Rapid disappearance of zaleplon from breast milk after oral administration to lactating women. J. Clin. Pharmacol. 39, 670–674.
Chaudron, L. H. and Jefferson, J. W. (2000) Mood stabilizers during breast-feeding: a review. J. Clin. Psychiatry 61, 79–90.
Iqbal, M. M., Gundlapalli, S. P., Ryan, W. G., et al. (2001) Effects of antimanic mood-stabilizing drugs on fetuses, neonates, and nursing infants. South. Med. J. 94, 304–322.
Yoshida, K., Smith, B., Craggs, M., et al. (1998) Neuroleptic drugs in breast-milk: a study of pharmacokinetics and of possible adverse effects in breast-fed infants. Psychol. Med. 28, 81–91.
Goldstein, D. J., Corbin, L. A., and Fung, M. C. (2000) Olanzapine-exposed pregnancies and lactation: early experience. J. Clin. Psychopharmacol. 20, 399–403.
Stowe, Z. N., Hostetter, A. L., Owens, M. J., et al. (2003) The pharmacokinetics of sertraline excretion into human breast milk: determinants of infant serum concentrations. J. Clin. Psychiatry 64, 73–80.
Epperson, N., Czarkowski, K. A., Ward-O’Brien, D., et al. (2001) Maternal sertraline treatment and serotonin transport in breast-feeding mother-infant pairs. Am. J. Psychiatry 158, 1631–1637.
Wisner, K. L., Perel, J. M., and Blumer, J. (1998) Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am. J. Psychiatry 155, 690–692.
Wisner, K. L., Perel, J. M., and Blumer, J. (1998) Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am. J. Psychiatry 155, 690–692.
Kristensen, J. H., Ilett, K. F, Dusci, L. J., et al. (1998) Distribution and excretion of sertraline and N-desmethylsertraline in human milk. Br. J. Clin. Pharmacol. 45, 453–457.
Mammen, O. K., Perel, J. M., Rudolph, G., et al. (1997) Sertraline and norsertraline levels in three breastfed infants. J. Clin. Psychiatry 58, 100–103.
Altshuler, L. L., Burt, V. K., McMullen, M., et al. (1995) breast-feeding and sertraline: a 24-hour analysis. J. Clin. Psychiatry 56, 243–245.
Suri, R., Stowe, Z. N., Hendrick, V., et al. (2002) Estimates of nursing infant daily dose of fluoxetine through breast milk. Biol. Psychiatry 52, 446–451.
Kristensen, J. H, Ilett, K. F., Hackett, L. P., et al. (1999) Distribution and excretion of fluoxetine and norfluoxetine in human milk. Br. J. Clin. Pharmacol. 48, 521–527.
Yoshida, K., Smith, B., Craggs, M., et al. (1998) Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br. J. Psychiatry 172, 175–178.
Taddio, A., Ito, S., and Koren, G. (1996) Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk. J. Clin. Pharmacol. 36, 42–47.
Lester, B. M., Cucca, J., Andreozzi, L., et al. (1993) Possible association between fluoxetine hydrochloride and colic in an infant. J. Am. Acad. Child Adolesc. Psychiatry 32, 1253–1255.
Burch, K. J. and Wells, B. G. (1992) Fluoxetine/norfluoxetine concentrations in human milk. Pediatrics 89(4 Pt. 1), 676–677.
Merlob, P., Mor, N., and Litwin, A. (1992) Transient hepatic dysfunction in an infant of an epileptic mother treated with carbamazepine during pregnancy and breast-feeding. Ann. Pharmacother. 26, 1563–1565.
Hendrick, V., Stowe, Z. N., Altshuler, L. L., et al. (2000) Paroxetine use during breast-feeding. J. Clin. Psychopharmacol. 20, 587–589.
Begg, E. J., Duffull, S. B., Saunders, D. A., et al. (1999) Paroxetine in human milk. Br. J. Clin. Pharmacol. 48, 142–147.
Ohman R., Hagg, S., Carleborg, L., et al. (1999) Excretion of paroxetine into breast milk. J. Clin. Psychiatry 60, 519–523.
Misri, S., Kim, J., Riggs, K.W., et al. (2000) Paroxetine levels in postpartum depressed women, breast milk, and infant serum. J. Clin. Psychiatry 61, 828–832.
Spigset, O., Carleborg, L., Norstrom, A., et al. (1996) Paroxetine level in breast milk. J. Clin. Psychiatry 57, 39.
Lee, A., Woo,., and Ito, S. (2004) Frequency of infant adverse events that are associated with citalopram use during breast-feeding. Am. J. Obstet. Gynecol. 190, 218–221.
Heikkinen, T., Ekblad, U., Kero, P., et al. (2002) Citalopram in pregnancy and lactation. Clin. Pharmacol Ther. 72, 184–191.
Schmidt, K., Olesen, O. V., and Jensen, P. N. (2000) Citalopram and breastfeeding: serum concentration and side effects in the infant. Biol. Psychiatry 47, 164–165.
Rampono, J., Kristensen, J. H., Hackett, L. P., et al. (2000) Citalopram and demethylcitalopram in human milk; distribution, excretion and effects in breast fed infants. Br. J. Clin. Pharmacol. 50, 263–268.
Jensen, P. N., Olesen, O. V,. Bertelsen, A., et al. (1997) Citalopram and desmethylcitalopram concentrations in breast milk and in serum of mother and infant. Ther. Drug Monit. 19, 236–239.
Spigset, O., Carieborg, L., Ohman, R., et al. (1997) Excretion of citalopram in breast milk. Br. J. Clin. Pharmacol. 44, 295–298.
Kristensen, J. H., Hackett, L. P., Kohan, R., et al. (2002) The amount of fluvoxamine in milk is unlikely to be a cause of adverse effects in breastfed infants. J. Hum. Lactation 18, 139–143.
Piontek, C. M., Wisner, K. L., Perel, J. M., et al. (2001) Serum fluvoxamine levels in breastfed infants. J. Clin. Psychiatry 62, 111–113.
Yoshida, K., Smith, B., Craggs, M.,et al. (1997)Investigation of pharmacokinetics and of possible adverse effects in infants exposed to tricyclic antidepressants in breast-milk. J. Affect. Disord. 43, 225–237.
Wright, S., Dawling, S., and Ashford, J. J. (1991) Excretion of fluvoxamine in breast milk. Br. J. Clin. Pharmacol. 31, 209.
Briggs, G. G., Samson, J. H., Ambrose, P. J., et al. (1993) Excretion of bupropion in breast milk. Ann. Pharmacother. 27, 431–433.
Baab, S. W., Peindl, K. S., Piontek, C M., and Wisner, K. L. (2002) Serumbupropion levels in 2 breastfeeding mother-infant pairs. J. Clin. Psych. 63, P.
Chaudron, L. H. and Schoenecker, C. J. (2004) Bupropion and breastfeeding: A case of a possible infant seizure. J. Clin. Psych. 65, 881–882.
Hendrick, V., Altshuler, L., Wertheimer, A., and Dunn, W. A. (2001) Venlafaxine and breast-feeding. Am. J. Psychiatry 158(12), 2089–2090.
Ilett, K. F., Kristensen, J. H., Hackett, L. P., et al. (2002) Distribution of venlafaxine and its O-desmethyl metabolite in human milk and their effects in breastfed infants. Br. J. Clin. Pharmacol. 53, 17–22.
Hart, S., Field, T., Jones, N., et al. (1999) Intrusive and withdrawn behaviours of mothers interacting with their infants and boyfriends. J. Child Psychol. Psychiatry Allied Disciplines 40, 239–245.
Caplan, H. L., Cogill, S. R., Alexandra, H., et al. (1989) Maternal depression and the emotional development of the child. Br. J. Psychiatry 154, 818–822.
Breznitz, Z. and Sherman, T. (1987) Speech patterning of natural discourse of well and depressed mothers and their young children. Child Dev. 58, 395–400.
Jones, N. A., Field T., and Davalos, M. (2000) Right frontal EEG asymmetry and lack of empathy in preschool children of depressed mothers. Child Psychiatry Hum. Dev. 30, 189–204.
Field, T., Lang, C., Yando, R., et al. (1995) Adolescents’ intimacy with parents and friends. Adolescence 30, 133–140.
Warner, R., Appleby, L., Whitton, A., et al. (1996) Demographic and obstetric risk factors for postnatal psychiatric morbidity. Br. J. Psychiatry 168, 607–611.
O’Hara, M. W., Stuart, S, Gorman, L. L., et al. (2000) Efficacy of interpersonal psychotherapy for postpartum depression. Arch. Gen. Psychiatry 57, 1039–1045.
Epperson, C. N., Wisner, K. L., and Yamamoto, B. (1999) Gonadal steroids in the treatment of mood disorders. Psychosom. Med. 61, 676–697.
Gregoire, A. J., Kumar, R., Everitt, B., et al. (1996) Transdermal oestrogen fo treatment of severe postnatal depression. Lancet 347, 930–933.
Stowe, Z. N., Casarella J., Landry J., et al. (1995) Sertraline in the treatment of women with postpartum major depression. Depression 3, 49–55.
Granger, A. C. and Underwood, M. R. (2001) Review of the role of progesterone in the management of postnatal mood disorders. J. Psychosom. Obstet. Gynecol. 22, 49–55.
Rabheru, K. (2001) The use of electroconvulsive therapy in special patient populations. Can. J. Psychiatry 46, 710–719.
Gruen, D. S. (1993) A group psychotherapy approach to postpartum depression. Int. J. Group Psychother. 43, 191–203.
Armstrong, K. L, Van Haeringen, A. R., Dadds, M. R., et al. (1998) Sleep deprivation or postnatal depression in later infancy: separating the chicken from the egg. J. Paediatr. Child Health 34, 260–262.
Corral, M., Kuan, A., and Kostaras, D. (2000) Bright light therapy’s effect on postpartum depression. Am. J. Psychiatry 157, 303–304.
Field, T., Grizzle, N., Scafidi F., et al. (1996) Massage and relaxation therapies’ effects on depressed adolescent mothers. Adolescence 31, 903–911.
Stamp, G. E., Williams, A. S., Crowther, C. A. (1995) Evaluation of antenatal and postnatal support to overcome postnatal depression: a randomized, controlled trial. Birth 22, 138–143.
Zlotnick, C., Johnson, S. L., Miller, I. W., et al. (2001) Postpartum depression in women receiving public assistance: pilot study of an interpersonal-therapyoriented group intervention. Am. J. Psychiatry 158, 638–640.
Murray, L., Cooper, P., and Hipwell, A. (2003) Mental health of parents caring for infants. Arch. Women’s Mental Health 6 (Suppl. 2), S71–77.
Wisner, K. L., Perel, J. M., Peindl, K. S., et al. (2004) Timing of depression recurrence in the first year after birth. J. Affect. Disord. 78, 249–252.
Wisner, K. L., Perel, J. M., Peindl, K. S., et al. (2001) Prevention of recurrent postpartum depression: a randomized clinical trial. J. Clin. Psychiatry 62, 82–86.
Hibbeln, J. R. (2002) Seafood consumption, the DHA content of mothers’ milk and prevalence rates of postpartum depression: a cross-national, ecological analysis. J. Affect. Disord. 69(1-3), 15–29.
Chaudron, L. H. and Pies, R. W. (2003) The relationship between postpartum psychosis and bipolar disorder: a review. J. Clin. Psychiatry 64, 1284–1292.
Burgess, P., Pirkis, J., Morton, J., et al. (2000) Lessons from a comprehensive clinical audit of users of psychiatric services who committed suicide. Psychiatr. Serv. 51, 1555–1560.
Nurnberg, H. G. (1989) An overview of somatic treatment of psychosis during pregnancy and postpartum. Gen. Hosp. Psychiatry 11, 328–338.
Hamilton, M. (1984) Depression and endogenicity. Acta Psychiatr. Belg. 84, 240–248.
Reed, P., Sermin, N., Appleby, L., et al. (1999) A comparison of clinical response to electroconvulsive therapy in puerperal and non-puerperal psychoses. J. Affect. Disord. 54, 255–260.
Cohen, L. S., Sichel, D. A., Robertson, L. M., et al. (1995)Postpartumprophylaxis for women with bipolar disorder. Am. J. Psychiatry 152, 1641–1645.
Viguera, A. C., Nonacs, R., Cohen, L. S., et al. (2000) Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. Am. J. Psychiatry 157, 179–184.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Neill Epperson, C., Ballew, J. (2006). Postpartum Depression. In: Hendrick, V. (eds) Psychiatric Disorders in Pregnancy and the Postpartum. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-013-3_3
Download citation
DOI: https://doi.org/10.1007/978-1-59745-013-3_3
Publisher Name: Humana Press
Print ISBN: 978-1-58829-486-9
Online ISBN: 978-1-59745-013-3
eBook Packages: MedicineMedicine (R0)